Atomwise is an AI drug discovery platform that uses convolutional neural networks to predict how small molecules bind to protein targets, enabling faster and cheaper identification of drug candidates. Its AtomNet technology has been used to screen billions of compounds for therapeutic potential.
Category
Healthcare
Subcategory
Drug Discovery
Free Tier
Not available yet
Paid Plans
Pharma and academic partnership programs
API Cost
Not available yet
Web App
Numerion Labs Trust & Security Report
Certifications, AI-training posture, and security controls, with sourced proof.
●GDPR (data transfer posture)
Verified against Numerion Labs's own trust and security pages. See the full report for sourced proof →
Region
Transfers outside EEA use standard contractual clauses or Binding Corporate Rules; no specific data residency guarantee documented.
Self-hostable
No
Virtual screening of billions of compounds against disease targetsIdentifying lead drug candidates for rare diseasesAcademic research partnerships for early drug discoveryHit-to-lead and lead optimization campaignsReducing preclinical drug discovery timelines and costs
// MORE IN DRUG DISCOVERY
BenevolentAIHealthcareDrug DiscoveryVerified
#drug discovery#knowledge graph
ExscientiaHealthcareDrug DiscoveryVerified
#drug design#ai molecules
Deep GenomicsHealthcareDrug Discovery
#genomics#genetic medicine
#drug discovery#molecular modeling#deep learning#protein binding#virtual screening